Stockreport

Agile Therapeutics, Inc. Presents Additional Analyses of AG200-15 (Twirla®) Phase 3 SECURE Study Results at the 2018 North American Forum on Family Planning (NAFFP)

Agile Therapeutics, Inc.  (AGRX) 
Last agile therapeutics, inc. earnings: 5/2 04:15 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.agiletherapeutics.com/investor-relations
PDF PRINCETON, N.J., Oct. 24, 2018 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (Nasdaq: AGRX), a women’s healthcare company, today announced an oral presentation regardi [Read more]